Combined approach to demonstrate acetylcholinesterase activity changes in the rat brain following tabun intoxication and its treatment

References

• Aroniadou-Anderjaska V, Figueiredo TH, Apland JP, Qashu F, Braga MF. 2009. Primary brain targets of nerve agents: the role of the amygdala in comparison to the hippocampus. Neurotoxicology 30:772–776.
   PubMed Web of Science ®Google Scholar
• Bajgar J. 2004. Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment. Adv Clin Chem 38:151–216.
   PubMed Web of Science ®Google Scholar
• Bajgar J, Fusek J, Kuca K, Bartosova L, Jun D. 2007a. Treatment of organophosphate intoxication using cholinesterase reactivators: facts and fiction. Mini Rev Med Chem 7:461–466.
   PubMed Web of Science ®Google Scholar
• Bajgar J, Kuca K, Jun D, Bartosova L, Fusek J. 2007b. Cholinesterase reactivators: the fate and effects in the organism poisoned with organophosphates/nerve agents. Curr Drug Metab 8:803–809.
   PubMed Web of Science ®Google Scholar
• Bajgar J, Hajek P, Slizova D, Krs O, Fusek J, Kuca K, Jun D, Bartosova L, Blaha V. 2007c. Changes of acetylcholinesterase activity in different rat brain areas following intoxication with nerve agents: biochemical and histochemical study. Chem Biol Interact 165:14–21.
   PubMed Web of Science ®Google Scholar
• Bajgar J, Karasova JZ, Kassa J, Cabal J, Fusek J, Blaha V, Tesarova S. 2010. Tabun-inhibited rat tissue and blood cholinesterases and their reactivation with the combination of trimedoxime and HI-6 in vivo. Chem Biol Interact 187:287–290.
   PubMedGoogle Scholar
• Benali A, Leefken I, Eysel UT, Weiler E. 2003. A computerized image analysis system for quantitative analysis of cells in histological brain sections. J Neurosci Methods 125:33–43.
   PubMed Web of Science ®Google Scholar
• Cassel G, Karlsson L, Waara L, Ang KW, Göransson-Nyberg A. 1997. Pharmacokinetics and effects of HI 6 in blood and brain of soman-intoxicated rats: a microdialysis study. Eur J Pharmacol 332:43–52.
   PubMed Web of Science ®Google Scholar
• Delfino RT, Ribeiro TS, Figueroa-Villar JD 2009. Organophosphorus compounds as chemical warfare agents: A review. J Braz Chem Soc 20:407–428.
   Web of Science ®Google Scholar
• Du D, Wang J, Smith JN, Timchalk C, Lin Y. 2009. Biomonitoring of organophosphorus agent exposure by reactivation of cholinesterase enzyme based on carbon nanotube-enhanced flow-injection amperometric detection. Anal Chem 81:9314–9320.
   PubMed Web of Science ®Google Scholar
• Eddleston M, Eyer P, Worek F, Mohamed F, Senarathna L, von Meyer L, Juszczak E, Hittarage A, Azhar S, Dissanayake W, Sheriff MH, Szinicz L, Dawson AH, Buckley NA. 2005. Differences between organophosphorus insecticides in human self-poisoning: a prospective cohort study. Lancet 366:1452–1459.
   PubMed Web of Science ®Google Scholar
• Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM. 1961. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88–95.
   PubMed Web of Science ®Google Scholar
• Gupta RC. 2004. Brain regional heterogeneity and toxicological mechanisms of organophosphates and carbamates. Toxicol Mech Methods 14:103–143.
   PubMed Web of Science ®Google Scholar
• Hajek P, Bajgar J, Slizova D, Krs O, Kuca K, Capek L, Fusek J. 2009. Intoxication with VX and Russian VX: Different inhibition of acetylcholinesterase in selected parts of the rat brain. Drug Chem Toxicol 32:1–8.
   PubMed Web of Science ®Google Scholar
• Hammond PI, Jelacic T, Padilla S, Brimijoin S. 1996. Quantitative, video-based histochemistry to measure regional effects of anticholinesterase pesticides in rat brain. Anal Biochem 241:82–92.
   PubMed Web of Science ®Google Scholar
• Jokanovic M, Prostran M. 2009. Pyridinium oximes as cholinesterase reactivators. Structure-activity relationship and efficacy in the treatment of poisoning with organophosphorus compounds. Curr Med Chem 16:2177–2188.
   PubMed Web of Science ®Google Scholar
• Kalász H, Furész J, Tekes K. 2009. Monitoring the pharmacokinetics of pyridinium aldoximes in the body. Mini Rev Med Chem 9:596–610.
   PubMedGoogle Scholar
• Kassa J. 2002. Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents. J Toxicol Clin Toxicol 40:803–816.
   PubMed Web of Science ®Google Scholar
• Kassa J, Kuca K, Cabal J, Paar M. 2006. A comparison of the efficacy of new asymmetric bispyridinium oximes (K027, K048) with currently available oximes against tabun by in vivo methods. J Toxicol Environ Health Part A 69:1875–1882.
   PubMed Web of Science ®Google Scholar
• Kassa J, Kuca K, Karasova J, Musilek K, Jun D, Bajgar J, Cabal J, Stetina R, Fusek J. 2007a. Development of new reactivators of tabun inhibited acetylcholinesterase and the evaluation of their efficacy by in vitro and in vivo methods. HFM-149 Symposium on “Defense against the effects of chemical toxic hazards: Toxicology, diagnosis and medical Countermeasures”. Edinburgh, Scotland (GBR), 8–10 October 2007. Session 4, OP Medical Countermeasures, No 17.
   Google Scholar
• Kassa J, Jun D, Kuca K, Bajgar J. 2007b. Comparison of reactivating and therapeutic efficacy of two salts of the oxime HI-6 against tabun, soman and cyclosarin in rats. Basic Clin Pharmacol Toxicol 101:328–332.
   PubMedGoogle Scholar
• Kassa J, Karasova J, Musilek K, Kuca K. 2008. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice. Toxicology 243:311–316.
   PubMed Web of Science ®Google Scholar
• Kassa J, Karasova JZ, Caisberger F, Bajgar J. 2009a. The influence of combinations of oximes on the reactivating and therapeutic efficacy of antidotal treatment of soman poisoning in rats and mice. Toxicol Mech Methods 19:547–551.
   PubMed Web of Science ®Google Scholar
• Kassa J, Karasova JZ, Musilek K, Kuca K. 2009b. A comparison of reactivating and therapeutic efficacy of newly-developed oximes (K156, K203) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice. Toxicol Mech Methods 19:346–350.
   PubMed Web of Science ®Google Scholar
• Kuca K, Jun D, Bajgar J. 2007. Structural factors influencing potency of currently used acetylcholinesterase reactivators for treatment of cyclosarin intoxications. Curr Pharm Des 13:3445–3452.
   PubMedGoogle Scholar
• Kuca K, Musilek K, Jun D, Bajgar J, Kassa J. (2009). Novel oximes. Chapter 66. In: Gupta, RC. ed, Handbook of Toxicology of Chemical Warfare Agents, 997–1021.London, UK: Elsevier, Academic Press.
   Google Scholar
• Laufer R, Kalasz H, Musilek K, Szegi P, Darvas F, Kuca K, Tekes K. 2010. Synthesis, antidotal effects and HLC behavior of some novel pyridinium aldoximes. Curr Org Chem 14:447–456.
   Web of Science ®Google Scholar
• Lojda Z, Gossrau RR, Schiebler TH. (1979). Enzyme histochemistry—A Laboratory Manual. New York: Springer Verlag.
   Google Scholar
• Marrs T, Maynard RL, Sidell FR. (1996). Chemical warfare agents—toxicology and treatment, New York: John Wiley & Sons, 83–113.
   Google Scholar
• Milatovic D, Jokanovic M. (2009) Pyridinium oximes as cholinesterase reactivators in the treatment of OP poisoning. Chapter 65. In: Gupta, RC, ed. Handbook of Toxicology of Chemical Warfare Agents. London, UK: Elsevier, Academic Press, 985–996.
   Google Scholar
• Musilek K, Jun D, Cabal J, Kassa J, Gunn-Moore F, Kuca K. 2007. Design of a potent reactivator of tabun-inhibited acetylcholinesterase–synthesis and evaluation of (E)-1-(4-carbamoylpyridinium)-4-(4-hydroxyiminomethylpyridinium)-but-2-ene dibromide (K203). J Med Chem 50:5514–5518.
   PubMed Web of Science ®Google Scholar
• Myhrer T. (2009) Prophylactic and therapeutic measures in nerve agent poisoning. Chapter 63. In: Gupta, RC, ed. Handbook of Toxicology of Chemical Warfare Agents. London, UK: Elsevier, Academic Press, 965–973.
   Google Scholar
• Paxinos G, Watson C. (1987). The rat brain in stereotactic coordinates. New York: Academic Press.
   Google Scholar
• Pejchal J, Osterreicher J, Kuca K, Jun D, Bajgar J, Kassa J. 2008. The influence of acetylcholinesterase reactivators on selected hepatic functions in rats. Basic Clin Pharmacol Toxicol 103:119–123.
   PubMed Web of Science ®Google Scholar
• Sakurada K, Matsubara K, Shimizu K, Shiono H, Seto Y, Tsuge K, Yoshino M, Sakai I, Mukoyama H, Takatori T. 2003. Pralidoxime iodide (2-pAM) penetrates across the blood-brain barrier. Neurochem Res 28:1401–1407.
   PubMed Web of Science ®Google Scholar
• Slízová D, Krs O, Bajgar J, Pospísilová B. 1995. Changes in microvascularization of some rat organs following soman poisoning. Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove 38:115–122.
   PubMedGoogle Scholar
• Voicu VA, Bajgar J, Medvedovici A, Radulescu FS, Miron DS. 2010. Pharmacokinetics and pharmacodynamics of some oximes and associated therapeutic consequences: a critical review. J Appl Toxicol 30:719–729.
   PubMed Web of Science ®Google Scholar
• Zdarova Karasova J, Novotny L, Antos K, Zivna H, Kuca K. 2010. Time-dependent changes in concentration of two clinically used acetylcholinesterase reactivators (HI-6 and obidoxime) in rat plasma determined by HPLC techniques after in vivo administration. Anal Sci 26:63–67.
   PubMedGoogle Scholar